139 related articles for article (PubMed ID: 34949502)
1. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
Rahmani B; Jahadi HR
Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
[TBL] [Abstract][Full Text] [Related]
3. An analysis of risk for secondary hemorrhage in traumatic hyphema.
Rahmani B; Jahadi HR; Rajaeefard A
Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid in the treatment of pediatric traumatic hyphema.
Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
[TBL] [Abstract][Full Text] [Related]
5. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for traumatic hyphema.
Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
Cochrane Database Syst Rev; 2011 Jan; (1):CD005431. PubMed ID: 21249670
[TBL] [Abstract][Full Text] [Related]
7. Is topical corticosteroid necessary in traumatic hyphema?
Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
[TBL] [Abstract][Full Text] [Related]
8. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
[TBL] [Abstract][Full Text] [Related]
9. Topical aminocaproic acid in the treatment of traumatic hyphema.
Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
[TBL] [Abstract][Full Text] [Related]
10. Comparison between Topical and Oral Tranexamic Acid in Management of Traumatic Hyphema.
Jahadi Hosseini SH; Khalili MR; Motallebi M
Iran J Med Sci; 2014 Mar; 39(2 Suppl):178-83. PubMed ID: 24753640
[TBL] [Abstract][Full Text] [Related]
11. Management of traumatic hyphema in children. An analysis of 340 cases.
Uusitalo RJ; Ranta-Kemppainen L; Tarkkanen A
Arch Ophthalmol; 1988 Sep; 106(9):1207-9. PubMed ID: 3415544
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, management and visual outcomes on patients with traumatic hyphema in a reference ophthalmological clinic in Colombia.
Galvis V; Pedraza-Concha A; Tello A; Plata ML; Escaf CL; Berrospi DR
Rom J Ophthalmol; 2020; 64(1):28-34. PubMed ID: 32292855
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and outcomes of hyphema: a single tertiary centre experience of 180 cases.
Iftikhar M; Mir T; Seidel N; Rice K; Trang M; Bhowmik R; Chun J; Goldberg MF; Woreta FA
Acta Ophthalmol; 2021 May; 99(3):e394-e401. PubMed ID: 33124159
[TBL] [Abstract][Full Text] [Related]
15. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
Goldberg MF
Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
[No Abstract] [Full Text] [Related]
16. The incidence of rebleeding in traumatic hyphema.
Witteman GJ; Brubaker SJ; Johnson M; Marks RG
Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
[TBL] [Abstract][Full Text] [Related]
17. Traumatic hyphema: outcomes of outpatient management.
Shiuey Y; Lucarelli MJ
Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
[TBL] [Abstract][Full Text] [Related]
18. Angle-recession glaucoma: long-term clinical outcomes over a 10-year period in traumatic microhyphema.
Ng DS; Ching RH; Chan CW
Int Ophthalmol; 2015 Feb; 35(1):107-13. PubMed ID: 25520267
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema.
Nasrullah A; Kerr NC
Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622
[TBL] [Abstract][Full Text] [Related]
20. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
Romano PE; Robinson JA
Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]